| European Federation of Internal Medicine

Human medicines European public assessment report (EPAR): Olanzapine Teva, olanzapine, Date of authorisation: 12/12/2007, Revision: 32, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Olanzapine Teva, olanzapine, Date of authorisation: 12/12/2007, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Pomalidomide Zentiva, pomalidomide, Date of authorisation: 24/07/2024, Revision: 1, Status: Authorised

Submitted by Anonymous (not verified) on 12 May 2025 - 14:20

Human medicines European public assessment report (EPAR): Pomalidomide Zentiva, pomalidomide, Date of authorisation: 24/07/2024, Revision: 1, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Pomalidomide Zentiva, pomalidomide, Date of authorisation: 24/07/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Levetiracetam Hospira, levetiracetam, Date of authorisation: 07/01/2014, Revision: 25, Status: Authorised

Submitted by Anonymous (not verified) on 12 May 2025 - 14:03

Human medicines European public assessment report (EPAR): Levetiracetam Hospira, levetiracetam, Date of authorisation: 07/01/2014, Revision: 25, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Levetiracetam Hospira, levetiracetam, Date of authorisation: 07/01/2014, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 46, Status: Authorised

Submitted by Anonymous (not verified) on 12 May 2025 - 14:00

Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 46, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 46, Status: Authorised

Human medicines European public assessment report (EPAR): Targretin, bexarotene, Date of authorisation: 29/03/2001, Revision: 24, Status: Authorised

Submitted by Anonymous (not verified) on 12 May 2025 - 13:45

Human medicines European public assessment report (EPAR): Targretin, bexarotene, Date of authorisation: 29/03/2001, Revision: 24, Status: Authorised

Read more about Human medicines European public assessment report (EPAR): Targretin, bexarotene, Date of authorisation: 29/03/2001, Revision: 24, Status: Authorised

PSUSA/00010571/202407

PSUSA/00003143/202409

PSUSA/00002643/202408

PSUSA/00010072/202409

PSUSA/00010670/202409

Human medicines European public assessment report (EPAR): Olanzapine Teva, olanzapine, Date of authorisation: 12/12/2007, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Pomalidomide Zentiva, pomalidomide, Date of authorisation: 24/07/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Levetiracetam Hospira, levetiracetam, Date of authorisation: 07/01/2014, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 46, Status: Authorised

Human medicines European public assessment report (EPAR): Targretin, bexarotene, Date of authorisation: 29/03/2001, Revision: 24, Status: Authorised

Newsletters

Latest Newsletters

You are here

Newsletters

Latest Newsletters